NO980324L - Didepsipeptidbaserte endoparasitticider, nye didepsipeptider og fremgangsmåte for fremstilling av disse - Google Patents

Didepsipeptidbaserte endoparasitticider, nye didepsipeptider og fremgangsmåte for fremstilling av disse

Info

Publication number
NO980324L
NO980324L NO980324A NO980324A NO980324L NO 980324 L NO980324 L NO 980324L NO 980324 A NO980324 A NO 980324A NO 980324 A NO980324 A NO 980324A NO 980324 L NO980324 L NO 980324L
Authority
NO
Norway
Prior art keywords
didepsipeptides
didepsipeptide
endoparasiticides
novel
preparation
Prior art date
Application number
NO980324A
Other languages
English (en)
Other versions
NO980324D0 (no
NO311566B1 (no
Inventor
Peter Jeschke
Juergen Scherkenbeck
Andrew Plant
Achim Harder
Norbert Mencke
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO980324D0 publication Critical patent/NO980324D0/no
Publication of NO980324L publication Critical patent/NO980324L/no
Publication of NO311566B1 publication Critical patent/NO311566B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/46—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
    • C07C275/58—Y being a hetero atom
    • C07C275/62—Y being a nitrogen atom, e.g. biuret
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/46—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
    • C07C275/48—Y being a hydrogen or a carbon atom
    • C07C275/50—Y being a hydrogen or an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19980324A 1995-08-11 1998-01-26 Anvendelse av didepsipeptidbaserte for bekjempelse av endoparasitter, nye didepsipeptider, fremgangsmåte forfremstilling av disse, endoparasittisid middel samt anvendelse avdidepsipeptider for fremstilling av endoparasittiside midler NO311566B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19529604A DE19529604A1 (de) 1995-08-11 1995-08-11 Endoparasitizide Mittel auf Basis von Didepsipeptiden, neue Didepsipeptide und ein Verfahren zu ihrer Herstellung
PCT/EP1996/003355 WO1997007093A1 (de) 1995-08-11 1996-07-30 Endoparasitizide mittel auf basis von didepsipeptiden, neue didepsipeptide und verfahren zu ihrer herstellung

Publications (3)

Publication Number Publication Date
NO980324D0 NO980324D0 (no) 1998-01-26
NO980324L true NO980324L (no) 1998-03-05
NO311566B1 NO311566B1 (no) 2001-12-10

Family

ID=7769288

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19980324A NO311566B1 (no) 1995-08-11 1998-01-26 Anvendelse av didepsipeptidbaserte for bekjempelse av endoparasitter, nye didepsipeptider, fremgangsmåte forfremstilling av disse, endoparasittisid middel samt anvendelse avdidepsipeptider for fremstilling av endoparasittiside midler

Country Status (26)

Country Link
US (2) US20020142969A1 (no)
EP (1) EP0843658B1 (no)
JP (3) JPH11511142A (no)
KR (1) KR19990036304A (no)
CN (2) CN1053657C (no)
AR (1) AR003977A1 (no)
AT (1) ATE229933T1 (no)
AU (1) AU707123B2 (no)
BG (1) BG64091B1 (no)
BR (1) BRPI9610049B1 (no)
CA (1) CA2228939C (no)
CZ (1) CZ41698A3 (no)
DE (2) DE19529604A1 (no)
DK (1) DK0843658T3 (no)
ES (1) ES2190476T3 (no)
HK (1) HK1017340A1 (no)
HU (1) HUP9802316A3 (no)
MX (1) MX9801133A (no)
NO (1) NO311566B1 (no)
NZ (1) NZ315642A (no)
PL (1) PL187412B1 (no)
SK (1) SK15598A3 (no)
TR (1) TR199800210T2 (no)
TW (1) TW492976B (no)
WO (1) WO1997007093A1 (no)
ZA (1) ZA966749B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458772B1 (en) 1909-10-07 2002-10-01 Medivir Ab Prodrugs
DE19962145A1 (de) 1999-12-22 2001-06-28 Bayer Ag Schädlingsbekämpfungsmittel/Depsipeptide
DE19962147A1 (de) 1999-12-22 2001-06-28 Bayer Ag Schädlingsbekämpfungsmittel / PF 1022-221
BRPI0620659A2 (pt) 2005-12-09 2017-10-31 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd método para a prevenção do aparecimento de sintomas de uma doença neurodegenerativa em um indivíduo predisposto à doença neurodegenerativa, método de redução de stress oxidante no cérebro de um indivíduo afligido com stress oxidante, método de tratamento de um indivíduo afligido com a degeneração cognitiva suave e composição farmacêutica
TW200744576A (en) * 2006-02-24 2007-12-16 Teva Pharma Propargylated aminoindans, processes for preparation, and uses thereof
US20110076377A1 (en) * 2007-11-28 2011-03-31 University Of Virginia Patent Foundation Ethoid compounds for use as food additives
TW200938203A (en) * 2007-12-17 2009-09-16 Intervet Int Bv Anthelmintic agents and their use
TW201111358A (en) 2009-06-18 2011-04-01 Intervet Int Bv Anthelmintic agents and their use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2619247C2 (de) * 1976-04-30 1986-04-03 Eckert, Heiner, Dipl.-Chem. Dr., 8000 München Verfahren zum Schutze reaktionsfähiger Amino-, Hydroxyl- und/oder Carboxylgruppen
FR2365341A1 (fr) * 1976-09-28 1978-04-21 Synthelabo Derives de l'acide l-(phenyl-3 amino-2 propionyloxy)-2 acetique
HU181008B (en) * 1980-01-18 1983-05-30 Richter Gedeon Vegyeszet Process for producing angiotenzin-ii analogues of antagonistic activity containing sarcosyl-group at the 1-positon,and an alpha-hydroxy-carboxylic acid at the 8-position
JPS606649A (ja) * 1983-06-24 1985-01-14 Daicel Chem Ind Ltd モノマ−
DK406686D0 (da) * 1986-08-26 1986-08-26 Hans Bundgaard Carboxylsyrederivater
ES2166359T3 (es) * 1992-03-17 2002-04-16 Fujisawa Pharmaceutical Co Derivado de depsipeptido, su produccion y uso.
DE4317458A1 (de) * 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
EP0685469A4 (en) * 1993-02-19 1996-04-03 Meiji Seika Kaisha DERIVATIVE OF PF 1022 USED AS A CYCLIC DEPSIPEPTIDE.
DE4317457A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4341991A1 (de) * 1993-12-09 1995-06-14 Bayer Ag Endoparasitizide Mittel auf Basis von offenkettigen Hexadepsipeptiden
DE4341992A1 (de) * 1993-12-09 1995-06-14 Bayer Ag Endoparasitizide Mittel auf Basis von offenkettigen Tetradepsipeptiden

Also Published As

Publication number Publication date
AR003977A1 (es) 1998-09-30
DK0843658T3 (da) 2003-04-14
CA2228939C (en) 2007-01-30
CZ41698A3 (cs) 1998-06-17
BRPI9610049B1 (pt) 2017-05-02
KR19990036304A (ko) 1999-05-25
PL324893A1 (en) 1998-06-22
CN1199394A (zh) 1998-11-18
JP2010222361A (ja) 2010-10-07
ES2190476T3 (es) 2003-08-01
BG102213A (en) 1998-08-31
BG64091B1 (bg) 2003-12-31
ATE229933T1 (de) 2003-01-15
US20040034048A1 (en) 2004-02-19
NO980324D0 (no) 1998-01-26
HUP9802316A2 (hu) 1999-02-01
NZ315642A (en) 2000-01-28
US20020142969A1 (en) 2002-10-03
SK15598A3 (en) 1998-09-09
ZA966749B (en) 1997-02-18
HK1017340A1 (en) 1999-11-19
BR9610049A (pt) 1999-07-06
NO311566B1 (no) 2001-12-10
AU6739496A (en) 1997-03-12
DE59610011D1 (de) 2003-01-30
AU707123B2 (en) 1999-07-01
TR199800210T2 (xx) 1998-08-21
JPH11511142A (ja) 1999-09-28
CA2228939A1 (en) 1997-02-27
EP0843658B1 (de) 2002-12-18
HUP9802316A3 (en) 2001-04-28
WO1997007093A1 (de) 1997-02-27
PL187412B1 (pl) 2004-07-30
JP2014159449A (ja) 2014-09-04
US7772190B2 (en) 2010-08-10
CN1254596A (zh) 2000-05-31
CN1053657C (zh) 2000-06-21
TW492976B (en) 2002-07-01
MX9801133A (es) 1998-05-31
DE19529604A1 (de) 1997-02-13
EP0843658A1 (de) 1998-05-27

Similar Documents

Publication Publication Date Title
DK0739898T3 (da) Phosphononmoneosternukleinsyrer, fremgangsmåde til fremstilling deraf og anvendelse deraf
NO973231D0 (no) Nye forbindelser
DK0729956T3 (da) Benzothi9phenforbindelser, emllemprodukter, præparater og fremgangsmåder
NO960472D0 (no) Nye forbindelser
DE69623475D1 (de) Schussfester gegenstand und herstellungsverfahren
TR199600144A2 (tr) Benzopiran ihtiva eden bilesikler ve bunlarin kullanimina ait usul.
DK0815130T3 (da) Caseinphosphopeptid, casein indeholdende samme og fremgangsmåde til præparationen deraf
BR9612963B8 (pt) Para-herquamidas e marcfortinas antiparasíticas.
DE69332370T2 (de) Netzwerkanalyseverfahren
DK0863856T3 (da) Komposteringssystem og fremgangsmåde
NO964095D0 (no) Nye hydroksypyridinoner
NO20000853L (no) Polysiloksanbaserte blokk-kopolymerer og fremgangsmÕte for fremstilling av disse
KR970002039A (ko) 급속발효 사료와 그 제조방법 및 용도
NO973741D0 (no) Fremgangsmåte for fremstilling av uorganiske granulater og anvendelse av disse
NO980324L (no) Didepsipeptidbaserte endoparasitticider, nye didepsipeptider og fremgangsmåte for fremstilling av disse
NO973682D0 (no) Fremgangsmåte for fremstilling av en glassmatte, den oppnådde matte og dennes anvendelse
NO941997D0 (no) Fremgangsmåte for belegging av fröplante og system for fremgangsmåtens utförelse
NO974058D0 (no) Fargestoff og framgangsmåte for framstilling av samme
NO982234D0 (no) Pesticidforbindelser, preparater og fremgangsmÕte for fremstilling av slike
NO20010575L (no) Nye antikonvulsiv virkende 4-amino-1-aryl-pyridin-2-oner og fremgangsmÕter for fremstilling av disse
IS4987A (is) PTX næm G prótein, framleiðsla þeirra og notkun
DE69614491T2 (de) 5HT1Dalpha und 5HT2A Ligande
NO974308D0 (no) Mikrobiologisk overvåkning
DK0853606T3 (da) 1,1-difluor-1,4-dichlorbutan og fremgangsmåde til dets fremstilling
FR2733230B1 (fr) Nouveaux derives d'ornithine, procede de preparation, utilisation et composition les comprenant

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE

MK1K Patent expired